Jazz Pharmaceuticals Inc (JAZZ) $28.06 -2.12%
Jazz Pharmaceuticals (JAZZ) is off 59 cents to $28.08 and Mar 27 and 28 puts have traded 1216 and 1346 contracts, respectively, and more than 70 percent at the offer. Implied volatility is up 6.5 percent to 66 and the action looks like opening put buying. Briefing attributes the weakness in the stock to “chatter related to drug not getting approval in the EU.”
Category: All Stocks, Pharmaceuticals & Biotechnology, Small Cap Stocks
Free Newsletter
If you enjoyed this article, sign up to receive more just like it.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.
